comparemela.com

Page 11 - Health Policy Manager News Today : Breaking News, Live Updates & Top Stories | Vimarsana

An average of 7 in 10 across G7 countries think their governments should force big pharma to share vaccine know-how

5 May 2021, 00:01 UTC G7 governments still refusing to waive intellectual property on Covid-19 vaccines, despite widespread public support People’s Vaccine Alliance calls for G7 leaders to support a vaccine patent waiver at today’s foreign and development ministers meeting in London. A supermajority of people in G7 countries believe that governments should ensure pharmaceutical companies share the formulas and technology to their vaccines, according to new polling from the People’s Vaccine Alliance. The public believes that pharmaceutical companies should be fairly compensated for developing vaccines, but should be prevented from holding a monopoly on the jabs. It comes as G7 foreign and development ministers meet in London, the group’s first in-person meeting in two years, and the general council of the World Trade Organisation (WTO) meets today online, while India’s death toll climbs.

Rich nations vaccinating one person every second while majority of the poorest nations are yet to give a single dose - Global Justice

Rich nations vaccinating one person every second while majority of the poorest nations are yet to give a single dose Rich nations vaccinating one person every second while majority of the poorest nations are yet to give a single dose Rich nations vaccinating one person every second while majority of the poorest nations are yet to give a single dose Date: 10 March 2021 US, UK and EU blocking proposals at WTO to help poorer countries get vaccines more quickly One year on from the declaration of the Covid-19 pandemic, the People’s Vaccine Alliance is warning that developing countries are facing critical shortages of oxygen and medical supplies to cope with Covid-19 cases yet the majority have been unable to administer a single dose of a Covid-19 vaccine. In contrast rich nations have vaccinated their citizens at a rate of one person per second over the last month.

Oxfam response to WTO TRIPS waiver for COVID-19 vaccines being blocked again by rich countries - a massive missed opportunity to speed up and scale up the production of lifesaving vaccines worldwide - World

Oxfam response to WTO TRIPS waiver for COVID-19 vaccines being blocked again by rich countries - a massive missed opportunity to speed up and scale up the production of lifesaving vaccines worldwide Format 11 Mar 2021 In response to calls for a waiver of Trade and Intellectual Property Rules (TRIPS) for COVID-19 vaccines, which is backed by more than 100 mostly developing countries, being blocked again at World Trade Organisation talks by rich countries, Oxfam’s Health Policy Manager, Anna Marriott, said: “This is a massive missed opportunity to speed up and scale up the production of lifesaving vaccines worldwide by waiving the intellectual property barriers that prevent more qualified manufacturers joining the effort.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.